Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules

scientific article published on 01 November 1998

Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-2168.1998.00915.X
P698PubMed publication ID9823912

P50authorMarkus SchwaigerQ57016855
P2093author name stringRömer W
Weber WA
Ziegler SI
Präuer HW
Treumann T
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectglucoseQ37525
positron emission tomographyQ208376
P304page(s)1506-1511
P577publication date1998-11-01
P1433published inBritish Journal of SurgeryQ4970212
P1476titleControlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules
P478volume85

Reverse relations

cites work (P2860)
Q36411892A method for model-free partial volume correction in oncological PET.
Q53158932Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Q86628849Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis
Q34013807Clinical imaging of cancer metastasis.
Q35769878Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography and Video-assisted Thoracoscopic Surgery in the Evaluation of Small Pulmonary Nodules in Patients with a History of Malignancy
Q57006924Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation
Q48538174Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology
Q44212161Diagnostic accuracy of semiquantitative analysis of positron emission tomography in radiologically indeterminate lung lesions
Q44598412Differentiating Solitary Pulmonary Metastases in Patients with Renal Cell Carcinomas by <sup>18</sup>F-Fluoro-2-Deoxyglucose Positron Emission Tomography – A Preliminary Report
Q44365801Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Q35008678Early lung cancer detection and treatment strategies
Q22306068Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?
Q43634477FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Q44549060Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia
Q46948766Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules
Q37643555Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
Q33902547Novel approaches to locally advanced unresectable non-small cell lung cancer
Q34569986Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
Q34088981Quantitative assessment of tumor metabolism using FDG-PET imaging
Q35894712Radionuclide imaging of thoracic malignancies
Q46104419Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests
Q37210598The role of positron emission tomography in the management of non-small cell lung cancer.
Q43681808Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions
Q35033424Value of FDG-PET in the management of non-small cell lung cancer.
Q82563242[Positron emission tomography for the study of solitary pulmonary nodules]
Q53672343[Positron emission tomography in respiratory medicine]

Search more.